日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab

对于经动脉放射栓塞治疗后完全缓解的晚期肝细胞癌,可采用转化疗法联合阿特珠单抗和贝伐珠单抗进行治疗。

Popovic, Peter; Kalamutova, Ana; Djokic, Mihajlo; Cuderman, Anka; Boltezar, Gasper; Trotovsek, Blaz

L-FABP as a Potential Biomolecular Marker of Liver Graft Injury

L-FABP作为肝移植损伤的潜在生物分子标志物

Kalamutova, Ana; Plevel, Danaja; Djokic, Mihajlo; Jerin, Ales; Trotovšek, Blaž; Petric, Miha